Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma. 1992

J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
Synertron, Inc., Madison, WI.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
November 2006, Cancer,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 1998, La Clinica terapeutica,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 1999, La Clinica terapeutica,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 1990, Bulletin du cancer,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 2006, Sarcoma,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
March 1999, European journal of cancer (Oxford, England : 1990),
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 1991, Cancer chemotherapy and pharmacology,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
March 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
January 1993, Cancer investigation,
J D Schiesel, and M Carabasi, and G Magill, and E Casper, and E Cheng, and L Marks, and J Feyzi, and N J Clendeninn, and R V Smalley
June 1987, American journal of clinical oncology,
Copied contents to your clipboard!